Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,287,012 papers from all fields of science
Search
Sign In
Create Free Account
ROAP protocol
Known as:
ARA-C/DNR/PRED/VCR
, Cytarabine/Daunorubicin/Prednisone/Vincristine
, DOAP
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (2)
Antineoplastic Combined Chemotherapy Protocols
Daunorubicin
Cytarabine
Daunorubicin Hydrochloride
Prednisone
Vincristine
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed…
Limin Liu
,
Qi Qu
,
+4 authors
Depei Wu
Leukemia research : a Forum for Studies on…
2015
Corpus ID: 206724493
2010
2010
Optimal interpretation for rhetorical relations
Henk Zeevat
2010
Corpus ID: 16674237
This paper explores the use of a simple and computational optimality theoretic pragmatics (OT pragmatics, OTP) to the analysis of…
Expand
2006
2006
DODA 0 . 1 : AN ONTOLOGY FOR LIGHTWEIGHT INTEGRATION OF SEMANTIC DATA ACCESS TECHNOLOGIES
G. Tummarello
,
C. Morbidoni
,
Michele Nucci
,
Richard Cyganiak
2006
Corpus ID: 14701841
Over the years, a number of studies and practical efforts have proposed technologies to retrieve, publish, cooperatively edit…
Expand
2006
2006
Anaphora Resolution by Default
A. Cohen
2006
Corpus ID: 17071043
The resolution of anaphora is dependent on a number of factors discussed in the literature: syntactic parallelism, topicality…
Expand
2001
2001
Results of Therapy with Interferon Alpha and Cyclic Combination Chemotherapy in Patients with Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Early Chronic Phase
F. Giles
,
H. Kantarjian
,
+6 authors
M. Talpaz
Leukemia and Lymphoma
2001
Corpus ID: 40511640
The objective of the study was to investigate the toxicity and efficacy of cyclic combination therapy offered to patients with Ph…
Expand
1999
1999
Performance optimization and light-beam-deviation analysis of the parallel-slab division-of-amplitude photopolarimeter.
A. El-Saba
,
R. Azzam
,
M. Abushagur
,
R. Azzam
Applied Optics
1999
Corpus ID: 14958401
A division-of-amplitude photopolarimeter that uses a parallel-slab multiple-reflection beam splitter was described recently [Opt…
Expand
1997
1997
[Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
R. M. Arana-Trejo
,
R. Ovilla-Martínez
,
+5 authors
S. Kofman‐Alfaro
Revista de investigacion clinica; organo del…
1997
Corpus ID: 41460783
OBJECTIVE To evaluate if human recombinant interferon alpha (IFN) combined with chemotherapy is able to suppress the Philadelphia…
Expand
1994
1994
[Treatment of promyelocytic leukemia with retinoic acid: results in Cuba].
P. Hernãndez
,
J. Carnot
,
+7 authors
B. Vergara
Sangre
1994
Corpus ID: 44690113
PURPOSE To assess the results attained with all-trans-retinoic acid (ATRA) in a group of Cuban patients with acute promyelocytic…
Expand
Highly Cited
1991
Highly Cited
1991
Intensive chemotherapy induction followed by interferon‐alpha maintenance in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia
H. Kantarjian
,
M. Talpaz
,
+6 authors
E. Freireich
Cancer
1991
Corpus ID: 23290259
In a pilot study, 32 patients with Philadelphia chromosome‐positive chronic myelogenous leukemia were treated with intensive…
Expand
1978
1978
Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin.
C. Coltman
,
G. Bodey
,
+9 authors
E. Gehan
Archives of Internal Medicine
1978
Corpus ID: 1140507
Adults (274) with acute leukemia (AML) were randomly assigned to one of three treatment regimens: vincristine, prednisone…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE